Integral Molecular, Inc.

10 patents currently held · Updated Nov 15, 2026

Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Ending by 2030

Nov 2031

Next term end

When these terms end

5 yrs10 yrs20 yrs

Held patents by the year their term ends

20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.

1 fee due Jun 5, 2027
The maintenance fee for Glucose Transporter 4 Antibodies, Methods of Making the Same, and Uses Thereof (US 11,834,497) comes due Jun 5, 2027. Unpaid by Dec 6, 2027, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

1 of the patents on this record was granted since Aug 17, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 10 of 10

Patent	Title	Status	Expires	Confidence
US 8,691,961	Flavivirus reporter virus and methods of making and using the same In force Term ends Nov 20, 2031 · From the USPTO record	In force	Term ends Nov 20, 2031	From the USPTO record
US 9,902,765	Antibodies against chikungunya virus and uses thereof In force Term ends Jul 21, 2034 · From the USPTO record	In force	Term ends Jul 21, 2034	From the USPTO record
US 11,834,497	Glucose Transporter 4 Antibodies, Methods of Making the Same, and Uses Thereof In force Term ends Dec 21, 2039 · High confidence	In force	Term ends Dec 21, 2039	High confidence
US 11,248,046	Claudin 6 Antibodies and Uses Thereof In force Term ends Feb 13, 2040 · High confidence	In force	Term ends Feb 13, 2040	High confidence
US 11,254,736	Antibodies Comprising a Common Light Chain and Uses Thereof In force Term ends Feb 13, 2040 · High confidence	In force	Term ends Feb 13, 2040	High confidence
US 12,428,474	Antibodies Comprising a Common Light Chain and Uses Thereof In force Term ends Feb 13, 2040 · High confidence	In force	Term ends Feb 13, 2040	High confidence
US 12,497,450	Claudin 6 Antibodies and Uses Thereof In force Term ends Feb 13, 2040 · High confidence	In force	Term ends Feb 13, 2040	High confidence
US 12,049,502	Antibodies Directed to Claudin 6, Including Bispecific Formats Thereof In force Term ends Nov 29, 2043 · High confidence	In force	Term ends Nov 29, 2043	High confidence
US 12,790,407	Claudin 182 Antibodies, Methods of Making the Same, and Uses Thereof In force Term ends Jun 13, 2045 · High confidence	In force	Term ends Jun 13, 2045	High confidence
US 12,545,726	Compositions and Methods Related to GPRC5D Binding Agents and Variants Thereof In force Term ends Jul 22, 2045 · High confidence	In force	Term ends Jul 22, 2045	High confidence

Also on record, not counted in the 10: 3 lapsed for an unpaid fee · 1 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built

Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Export every term end as CSV · Pro

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

3 pending · 3 no status recorded

List them